Misaki Wayengera

738 total citations
43 papers, 188 citations indexed

About

Misaki Wayengera is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Misaki Wayengera has authored 43 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 17 papers in Infectious Diseases and 14 papers in Epidemiology. Recurrent topics in Misaki Wayengera's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (6 papers) and Virology and Viral Diseases (5 papers). Misaki Wayengera is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (6 papers) and Virology and Viral Diseases (5 papers). Misaki Wayengera collaborates with scholars based in Uganda, United Kingdom and United States. Misaki Wayengera's co-authors include Henry Kajumbula, Moses Joloba, Samuel Kyobe, Noah Kiwanuka, Samuel Kirimunda, Benon Asiimwe, Chester Brown, Gabriel Anabwani, Eddie M. Wampande and Janusz T. Pawęska and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Lancet Infectious Diseases.

In The Last Decade

Misaki Wayengera

39 papers receiving 182 citations

Peers

Countries citing papers authored by Misaki Wayengera

Since Specialization

Citations

This map shows the geographic impact of Misaki Wayengera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misaki Wayengera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misaki Wayengera more than expected).

Fields of papers citing papers by Misaki Wayengera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misaki Wayengera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misaki Wayengera. The network helps show where Misaki Wayengera may publish in the future.

Co-authorship network of co-authors of Misaki Wayengera

This figure shows the co-authorship network connecting the top 25 collaborators of Misaki Wayengera. A scholar is included among the top collaborators of Misaki Wayengera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misaki Wayengera. Misaki Wayengera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Field evaluation of a rapid antigen test for mpox in the Democratic Republic of the Congo and Uganda: a multicentre, prospective, diagnostic accuracy study 2025 ·The Lancet Infectious Diseases ·Barnabas Bakamutumaho, L.L. David, Winters Muttamba, (unknown), Henry Kyobe Bosa, (unknown), (unknown), (unknown), Misaki Wayengera, Alison Sandeman, Matthew T. G. Holden, Patrick DMC Katoto, Bruce Kirenga, Deborah A. Williamson, Wilber Sabiiti	1
2	Description of clinical and histopathological characteristics of keloids in a sub-Saharan African population 2025 ·Skin Health and Disease ·(unknown), Misaki Wayengera, Noah Kiwanuka, Ian G. Munabi, Haruna Muwonge, (unknown), (unknown), (unknown), Moses Joloba, (unknown)	0
3	High prevalence and non-suppression of HIV/AIDS in the East and Central African region heightens risk of severe outcomes for Clade I monkeypox virus infection, and may be a driver for subsequent adaptation 2024 ·St Andrews Research Repository (St Andrews Research Repository) ·Henry Kyobe Bosa, Winters Muttamba, Barnabas Bakamutumaho, (unknown), (unknown), (unknown), Wilber Sabiiti, (unknown), Jacqueline Weyer, Joel M Francis, Ntuli Kapologwe, Patrick DMC Katoto, Bruce Kirenga, Misaki Wayengera	1
4	“A Call To Action”: The need for genetic counseling in Uganda 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), John Mukisa, Misaki Wayengera	2
5	A Cross-Sectional Study on Knowledge and Attitudes About Organ Donation and Transplantation in an Urban Population in a Low-Income Country 2023 ·Transplantation Proceedings ·Olivia Kituuka, Moses Ocan, (unknown), (unknown), Charles Ibingira, Misaki Wayengera	1
6	Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial 2021 ·BMC Infectious Diseases ·Pauline Byakika‐Kibwika, Christine Sekaggya‐Wiltshire, (unknown), Jane Nakibuuka, Joseph Musaazi, James Kayima, Cornelius Sendagire, David B. Meya, Bruce Kirenga, (unknown), Arthur Kwizera, (unknown), (unknown), Misaki Wayengera, Henry Mwebesa, Moses R. Kamya, William Bazeyo	3
7	Variations in Trim5α and Cyclophilin A genes among HIV-1 elite controllers and non controllers in Uganda: a laboratory-based cross-sectional study 2020 ·Retrovirology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rose Nabatanzi, (unknown), Gerald Mboowa, Alex Kayongo, Misaki Wayengera, Obondo James Sande	2
8	Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection 2018 ·BMC Infectious Diseases ·Misaki Wayengera, David Patrick Kateete, Benon Asiimwe, Moses Joloba	1
9	Selecting a Laboratory Information Management System for Biorepositories in Low- and Middle-Income Countries: The H3Africa Experience and Lessons Learned 2017 ·Biopreservation and Biobanking ·Samuel Kyobe, (unknown), (unknown), (unknown), Edgar Kigozi, Fred Ashaba Katabazi, Misaki Wayengera, Moses Joloba, (unknown), (unknown), Alash’le Abimiku, (unknown), (unknown), (unknown), Alan Christoffels, (unknown), Elizabeth Mayne, (unknown), (unknown), (unknown)	7
10	Sero-diagnosis of Active Mycobacterium tuberculosis Disease among HIV Coinfected Persons using Thymidylate Kinase based Antigen and Antibody Capture Enzyme Immuno-Assays 2017 ·PubMed ·Misaki Wayengera, (unknown), (unknown), (unknown), David Patrick Kateete, Eddie M. Wampande, Samuel Kirimunda, Lois Bayigga, (unknown), (unknown), Benon Asiimwe, Moses Joloba	4
11	The collaborative African genomics network training program: a trainee perspective on training the next generation of African scientists 2017 ·Genetics in Medicine ·Busisiwe Mlotshwa, Savannah Mwesigwa, Gerald Mboowa, Lesedi Williams, Gaone Retshabile, Adeodata Kekitiinwa, Misaki Wayengera, Samuel Kyobe, Chester Brown, Neil A. Hanchard, Graeme Mardon, Moses Joloba, Gabriel Anabwani, Sununguko Wata Mpoloka	16
12	In Vitro Transduction and Target-Mutagenesis Efficiency of HIV-1 pol Gene Targeting ZFN and CRISPR/Cas9 Delivered by Various Plasmids and/or Vectors: Toward an HIV Cure 2017 ·AIDS Research and Human Retroviruses ·Moses Okee, (unknown), (unknown), Moses Joloba, (unknown), Bernard S. Bagaya, Misaki Wayengera	6
13	Zinc finger nucleases for targeted mutagenesis and repair of the sickle-cell disease mutation: An in-silico study 2012 ·PubMed ·Misaki Wayengera	1
14	Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors 2011 ·Theoretical Biology and Medical Modelling ·Misaki Wayengera	11
15	On the general theory of the origins of retroviruses 2010 ·Theoretical Biology and Medical Modelling ·Misaki Wayengera	4
16	A model for mapping of Ebola and Marburg RNA integration sites in rhesus Macaca mulatta genome in silico: Ebola virus acceptors sites located on chromosomes 4, 6, 7, 8, 9, 14 and 15. 2009 ·AFRICAN JOURNAL OF BIOTECHNOLOGY ·Misaki Wayengera, (unknown), (unknown), (unknown), (unknown)	1
17	Theoretical basis for reducing time-lines to the determination of positive Mycobacterium tuberculosis cultures using thymidylate kinase (TMK) assays 2009 ·Theoretical Biology and Medical Modelling ·Misaki Wayengera	4
18	Emphasizing the vitality of genomics related research in the area of infectious diseases 2008 ·Scientific Research and Essays ·Misaki Wayengera, (unknown)	4
19	Frequency and site mapping of HIV-1/SIVcpz, HIV- 2/SIVsmm and other SIV gene sequence cleavage by various bacteria restriction enzymes: Precursors for a novel HIV inhibitory product 2007 ·AFRICAN JOURNAL OF BIOTECHNOLOGY ·Misaki Wayengera, (unknown), (unknown)	7
20	PREX-1979: Modeling the first ever prototype of a new generation of microbicides for preventing HIV infection among high risk women 2007 ·AFRICAN JOURNAL OF BIOTECHNOLOGY ·Misaki Wayengera	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact